Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HCG Activation of Dormant Follicles in POI
NCT06754332Phase 1Not yet recruiting
- Sponsor
- The Fourth Affiliated Hospital of Zhejiang University School of Medicine
- Start
- Apr 2025
- Primary completion
- Apr 2028
- Modality
- Recombinant Proteins and Enzymes
01
Overview
Phase 1, open-label trial of human chorionic gonadotropin in premature ovarian insufficiency (POI) (2 arms), sponsored by The Fourth Affiliated Hospital of Zhejiang University School of Medicine. Primary endpoint: Follicle growth observation. Planned start Apr 2025; status: not yet recruiting.
02
Drugs
human chorionic gonadotropin
03
Conditions
premature ovarian insufficiency (POI)
Beyond the preview
Go deeper on NCT06754332.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06754332.